TradesZ
Top 10 stocks to add now

Is THRM a buy? — what our data shows

⚡ TradesZ research ·Updated July 6, 2026 ·~2 min read ·Grounded in SEC data

Gentherm makes the technology that keeps you comfortable in your car — think heated and cooled seats, steering wheels, and cup holders — and is now pushing that same thermal know-how into electric vehicle batteries and medical devices.

Everyone wishes they'd bought Nvidia early. Here's how to spot the next one.

The biggest winners of the last decade had one thing in common. Our data follows those exact moves — and turns them into 10 names to watch right now.

The big names in the AI, Space, Nuclear and Robotics race. The window to get in early is closing fast. Don't wait.

See the top 10 stocks now — free ›

What our data shows

Our data on Gentherm tells a pretty exciting story. The company has quietly won over $2 billion in new contracts focused on electric vehicles, which shows automakers are betting on their tech for the EV era — not just old-school heated seats. The really big move, though, is a planned merger with a division of Modine that would nearly double their size and create a serious thermal-technology powerhouse. We tag Gentherm under Battery and Climate tech — two themes that are very much in the spotlight right now. The main risks to watch: if EV adoption stalls or the merger hits unexpected bumps, the growth story gets a lot harder.

Our research
What you see
THRM: Heating up vehicle comfort, cooling down risk
What it means
Catalysts we track: Expected closing of Modine Performance Technologies combination by end of 2026, creating $2.6B revenue thermal platform.; FDA 510(k) decision and initial ThermAffyx revenue expected in Q3 2026 for patient safety system.; Ramp‑up of KUKA Home co‑branded thermal comfort furniture line in Asia through late 2026..
How to read it
This is our research view (our own tier scoring) — not a smart-money flow signal and not advice.
→ Read the full analysis

The takeaway

Neutral

The next few months are genuinely pivotal — an earnings update in August and a key medical-device regulatory decision around the same time will tell you a lot about whether this story is on track. Think of it as a company in the middle of a major transformation: the upside is real, but so is the execution risk.

But watch out
Automotive slowdown or EV adoption hiccups could cut demand for comfort systems and delay new program launches.
📈
Before you buy

Thinking about THRM?

Our data likes 10 other stocks even more right now — under-the-radar names we believe have monster upside potential. Get the free list before the crowd catches on.

Show me the 10 stocks — free →
Free · no credit card · unsubscribe in one click

Have your own question?

Ask in plain English — our data answers. Free for retail readers.

Ask a question →

Informational research, not personalized investment advice.